fda to reconsider tirzepatide Zepbound shortage ends, impacts patients, compounding pharmacies The FDA says the Zepbound

The researchers suggested that as a person loses weight and their metabolic health improves, the physical burden of obesity-related complications decreases, leading to an increase in energy

Try not to leave the medication in a hot car or anywhere it might get direct sunlight, just to be safe.

It is crucial for patients to recognize when they should reach out to their healthcare provider

Some patients may experience loss of lean mass alongside fat loss, which could theoretically contribute to feelings of weakness or achiness, particularly if protein intake is inadequate

Janani Priya Editor: Dr

These trials inform Anthems clinical policy, but the companys medical necessity criteria are stricter than the FDA label